-transparent.png){kind=logo}
Peritonitis is the most frequent complication in patients under continuous ambulatory peritoneal dialysis. Intraperitoneal administration of ceftazidime in a dose of 125 mg per liter dialysate achieved serum concentrations higher than the minimal inhibitory concentrations of most organisms in spite of low peritoneal clearance. Serum concentration was stable up to the 120th hour. Dialysate osmolarity had no influence on serum concentration, peritoneal absorption or clearance of ceftazidime. Peritoneal inflammation did not cause changes in ceftazidime pharmacokinetics. Ceftazidime used alone as the first choice treatment was successful in 85%, of cases.
Related Publications
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
January 1981,
Clinical and experimental dialysis and apheresis,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
January 1987,
European journal of clinical pharmacology,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
February 1988,
International journal of clinical pharmacology, therapy, and toxicology,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
April 1988,
Pharmaceutisch weekblad. Scientific edition,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
October 1996,
Clinical pharmacokinetics,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
September 1987,
The American journal of cardiology,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
February 1988,
Antimicrobial agents and chemotherapy,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
May 1993,
Journal of clinical pharmacology,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
May 1988,
Pathologie-biologie,
J P Ryckelynck, and
M Vergnaud, and
B Hurault de Ligny, and
G Allouche, and
B Malbruny, and
C Morel
November 1990,
The Journal of antimicrobial chemotherapy,
